A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Fosfomycin
Risedronic acid
The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftriaxone is combined with Risedronic acid.
Fosfomycin
Calcium chloride
The risk or severity of adverse effects can be increased when Calcium chloride is combined with Ceftriaxone.
Fosfomycin
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Ceftriaxone.
Fosfomycin
BCG vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Ceftriaxone.
Fosfomycin
Hygromycin B
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Hygromycin B.
Fosfomycin
Dihydrostreptomycin
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Dihydrostreptomycin.
Fosfomycin
Puromycin
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Puromycin.
Fosfomycin
Neamine
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Neamine.
Fosfomycin
Apramycin
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Apramycin.
Fosfomycin
Geneticin
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Geneticin.
Fosfomycin
Paromomycin
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Paromomycin.
Fosfomycin
Loxoprofen
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Loxoprofen.
Fosfomycin
Lithium citrate
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Lithium citrate.
Fosfomycin
Lithium cation
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Lithium cation.
Fosfomycin
Givosiran
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Givosiran.
Fosfomycin
Phenazopyridine
The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Phenazopyridine.
Fosfomycin
Prednisolone phosphate
The excretion of Prednisolone phosphate can be decreased when combined with Ceftriaxone.
Fosfomycin
Baricitinib
The excretion of Baricitinib can be decreased when combined with Ceftriaxone.
Fosfomycin
Taurocholic acid
The excretion of Taurocholic acid can be decreased when combined with Ceftriaxone.
Fosfomycin
Sitagliptin
The excretion of Sitagliptin can be decreased when combined with Ceftriaxone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3